We need individuals between the ages of 55 and 85 who have dementia or memory concerns for a year-long study of an investigational medication that may slow or inhibit the progression of Alzheimer’s disease.
Qualified Participants Must:
Be 55 to 85 years of age
Be concerned about memory loss
Qualified Participants May Receive:
Eligible participants will receive study-related care, monitoring and investigational medication or placebo. Compensation for time and travel may be available to patient and caregiver. All studies administered by a board certified physician.